To extend our findings on the ability of BAY651942 to partially inhibit TGF-β/TNF–α-induced RPE–EMT, we tested whether it could modulate the effect of RPE–EMT on expression of complement genes and other AMD risk genes. This evidence concerns the gene TNF and age-related macular degeneration.